BI
BIOVERSYS AG
Grant-FundedCORDISProgress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline
Biotech · Deep Tech
BIOVERSYS AG is a private SME recorded in CORDIS in Switzerland, with participation in 4 EU research and innovation projects. Its recorded projects include “Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€7,733,118
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇨🇭Switzerland
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
BIOVERSYS AG is a private SME recorded in CORDIS in Switzerland, with participation in 4 EU research and innovation projects. Its recorded projects include “Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
BiotechDeep Tech
Tags:BiotechDeep Tech
Company Info
BIOVERSYS AG Info
Funding
EU Grants€7,733,118